• Login
    View Item 
    •   Home
    • UMass Chan Faculty and Staff Research and Publications
    • COVID-19 Publications by UMass Chan Authors
    • View Item
    •   Home
    • UMass Chan Faculty and Staff Research and Publications
    • COVID-19 Publications by UMass Chan Authors
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of eScholarship@UMassChanCommunitiesPublication DateAuthorsUMass Chan AffiliationsTitlesDocument TypesKeywordsThis CollectionPublication DateAuthorsUMass Chan AffiliationsTitlesDocument TypesKeywordsProfilesView

    My Account

    LoginRegister

    Help

    AboutSubmission GuidelinesData Deposit PolicySearchingUsage StatisticsAccessibilityTerms of UseWebsite Migration FAQ

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    US companies' COVID patents: Will "the saints go marching in"?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Pederson, Thoru
    UMass Chan Affiliations
    Department of Biochemistry and Molecular Pharmacology
    Document Type
    Editorial
    Publication Date
    2021-09-06
    Keywords
    Immunology and Infectious Disease
    Infectious Disease
    Microbiology
    Technology and Innovation
    Virus Diseases
    
    Metadata
    Show full item record
    Link to Full Text
    https://doi.org/10.1096/fj.202101282
    Abstract
    Many pandemic issues have been swirling around in our country, and most have received extensive media coverage, most notably vaccine hesitancy/resistance, the Delta variant, and the continuing extreme importance of masking. Another is the collective angst over the time it is taking the FDA to issue full approvals of the earliest vaccines to apply for it. (It is anticipated that at least one vaccine will have received this by the time this editorial appears.) In the background, not exactly sotto voce but receiving less print, is the question of whether the US government might exercise its so-called march-in authority on the relevant patents. Its statutory footing and operative domain are often misunderstood, and here I seek to clarify this for our readers. I am motivated to do so because I did not initially understand it either.
    Source

    Pederson T. US companies' COVID patents: Will "the saints go marching in"? FASEB J. 2021 Oct;35(10):e21879. doi: 10.1096/fj.202101282. PMID: 34486747. Link to article on publisher's site

    DOI
    10.1096/fj.202101282
    Permanent Link to this Item
    http://hdl.handle.net/20.500.14038/27553
    PubMed ID
    34486747
    Related Resources

    Link to Article in PubMed

    ae974a485f413a2113503eed53cd6c53
    10.1096/fj.202101282
    Scopus Count
    Collections
    COVID-19 Publications by UMass Chan Authors

    entitlement

    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Lamar Soutter Library, UMass Chan Medical School | 55 Lake Avenue North | Worcester, MA 01655 USA
    Quick Guide | escholarship@umassmed.edu
    Works found in eScholarship@UMassChan are protected by copyright unless otherwise indicated.
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.